Sergey Sulima

Helmholtz Zentrum München

Sergey obtained a PhD in molecular and cell biology at the University of Maryland (USA) in 2013, and afterwards carried out post-doctoral research in oncology and hematology at the University of Leuven (Belgium). His scientific bibliography includes authorships on 16 publications in leading journals such as Cancer Discovery, Leukemia, Nature, and Nucleic Acids Research. In addition to his scientific research experience, Sergey has designed and taught a variety of university courses including anatomy and physiology, biochemistry, general chemistry, quantitative chemistry, molecular biology, microbiology, and virology. From 2018 to 2020, Sergey was a scientific and medical writer at BioNTech SE (Mainz, Germany), a biopharmaceutical company specializing in cancer immunotherapy and, most recently, COVID19 vaccination. Since May 2020, Sergey has been a scientific writer and publications manager at the Institute for Medical and Biological Imaging at the Helmholtz Center in Munich.